Impact of digital health support on symptom and side-effect management for advanced/metastatic sarcoma

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study will follow adults with locally advanced or metastatic sarcoma to see how a personalized web-based support platform affects quality of life during standard treatments. Participants will use the digital platform to report symptoms and receive tailored guidance, with the aim of improving daily living and symptom control. The study will collect patient-reported outcomes to understand whether ongoing digital support can complement usual care. Eligible patients must be at least 18, able to navigate digital tools, and starting or currently receiving standard therapies such as surgery, radiotherapy, chemotherapy, immunotherapy, targeted therapy, or hormonal therapy. Exclusion criteria include limited ability to report online, poor performance status, limited life expectancy, or participation in another interventional trial with investigational agents or devices.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age of ≥ 18 years.
* Diagnosis of locally advanced or metastatic sarcoma of any location and origin.
* Ability to understand and operate in a digital environment.
* Patients planned to start standard of care treatment within the next month, or are currently undergoing standard of care treatment of any line.
* Treatments include surgery, radiotherapy, chemotherapy, immunotherapy, targeted therapy, hormonal therapy, or any combination of the above.

Exclusion Criteria:

* Limited ability or willingness to report side-effects on an online platform.
* Performance status \>3.
* Life expectancy of \<6 months.
* Participation in an interventional clinical trial with investigational drugs or devices.

Where it's running

• 401 General Military Hospital
  Athens, Greece Recruiting
• 251 Air Force General Hospital
  Athens, Greece Recruiting
• Attikon Hospital, 2nd clinic
  Athens, Greece Recruiting
• Attikon Hospital, 4th clinic
  Athens, Greece Recruiting
• Hygeia hospital
  Athens, Greece Recruiting
• Mitera hospital
  Athens, Greece Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Targeted radiation therapy for young patients with metastatic sarcoma

  This study is testing if a special type of radiation therapy can help young patients with metastatic sarcoma live longer and have fewer health issues compared to those who don’t receive it.

  Recruiting at 3 sites Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Washington D.C., District of Columbia and 2 other locations · NCT06796543

• Using 64Cu-LNTH-1363S for imaging in patients with sarcoma or gastrointestinal cancers

  This study is testing a new imaging agent called 64Cu-LNTH-1363S in patients with metastatic sarcoma or gastrointestinal cancers to see how safe it is and how well it works for imaging their tumors.

  Recruiting at 5 sites Phase 1/2 Lantheus Medical Imaging · Duarte, California and 4 other locations · NCT06298916

• Using Cytalux for better cancer surgery in children

  This study is testing if a special imaging agent called Cytalux can help doctors find and remove lung tumors more effectively during surgery in children with cancer.

  Recruiting Phase 1 Ann & Robert H Lurie Children's Hospital of Chicago · Chicago, Illinois · NCT06235125

• Using engineered T cells to treat advanced sarcoma in young patients

  This study is testing if special T cell treatments can help young patients with advanced sarcoma who haven't had success with regular treatments.

  Recruiting Phase 1 Instituto de Investigación Hospital Universitario La Paz · Madrid · NCT06087341

• At-home cancer treatment versus clinic-based treatment for advanced cancer patients

  This study tests whether giving cancer treatment at home is better for comfort and satisfaction compared to getting it at a clinic for people with advanced cancer.

  Recruiting at 2 sites Phase 2 Mayo Clinic · Jacksonville, Florida and 1 other locations · NCT05969860

• Testing a new combination of chemotherapy drugs for advanced sarcoma

  This study is testing a new combination of chemotherapy drugs to see if it can help people with advanced sarcoma feel better and manage their disease.

  Recruiting at 15 sites Phase 1 National Cancer Institute (NCI) · Los Angeles, California and 15 other locations · NCT05711615

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.